FDA warns Novo Nordisk over unreported potential Ozempic side effects
10/03/2026-19:50 10/03/2026-19:56 חדשות CBS News דיווח
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
